Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention aGVHD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT02895412
What this trial is testing

Infection and Tumour Antigen Cellular Therapy

Who this might be right for
Leukemia, Myelocytic, Acute
University of Sydney 20
Large-scale testing (Phase 3)Study completedNCT02665377
What this trial is testing

Prevention of Akute Kidney Injury, Hearttransplant, ANP

Who this might be right for
Acute Kidney Injury
Sahlgrenska University Hospital 86
Testing effectiveness (Phase 2)Ended earlyNCT03246906
What this trial is testing

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+14 more
Fred Hutchinson Cancer Center 150
Large-scale testing (Phase 3)WithdrawnNCT01231724
What this trial is testing

Topical Allstate and Nasal Allergen Challenge

Who this might be right for
Allergic Rhinitis
University of Chicago
Testing effectiveness (Phase 2)Ended earlyNCT02922413
What this trial is testing

Panhematin for Prevention of Acute Attacks of Porphyria

Who this might be right for
Acute Intermittent PorphyriaHereditary CoproporphyriaVariegate Porphyria
The University of Texas Medical Branch, Galveston 13
Not applicableStudy completedNCT00963391
What this trial is testing

"Alcohol Based Hand Sanitizers for the Prevention of Acute Diarrheal Disease and Acute Respiratory Infection in Children Under 5 Attending Childcare Centers in Bogotá, Cundinamarca and Tolima, in Colombia: a Cluster Randomized Control Trial"

Who this might be right for
Acute Diarrheal DiseaseAcute Respiratory Infection
Fundación Santa Fe de Bogota 1,727
Not applicableStudy completedNCT04611061
What this trial is testing

Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers

Who this might be right for
Acute Upper Respiratory Tract InfectionInfluenzaRespiratory Viral Infection
Nearmedic Plus LLC 204
Large-scale testing (Phase 3)Active Not RecruitingNCT04948203
What this trial is testing

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

Who this might be right for
Pulmonary FibrosisCOVID-19 PneumoniaLong COVID
University of Chicago 60
Large-scale testing (Phase 3)WithdrawnNCT04938323
What this trial is testing

Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly

Who this might be right for
Acute Respiratory Infection
Harvard Medical School (HMS and HSDM)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04572815
What this trial is testing

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Who this might be right for
Hematologic and Lymphocytic DisorderHematopoietic and Lymphoid System Neoplasm
Fred Hutchinson Cancer Center 116
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT05886816
What this trial is testing

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

Who this might be right for
SARS-CoV InfectionCOVID-19
University of Texas Southwestern Medical Center 122
Large-scale testing (Phase 3)Study completedNCT03594149
What this trial is testing

Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Centre Henri Becquerel 60
Large-scale testing (Phase 3)UnknownNCT00624143
What this trial is testing

Antifungal Prophylaxis in Pediatric Acute Leukemia

Who this might be right for
Pediatric Acute Leukemia Induction
All India Institute of Medical Sciences 100
Large-scale testing (Phase 3)Study completedNCT00571649
What this trial is testing

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

Who this might be right for
Venous Thromboembolism
Bayer 8,101
Not applicableStudy completedNCT01621152
What this trial is testing

PRevention of Acute Kidney Injury Initiated With Electronic Surveillance Enhancement

Who this might be right for
Acute Kidney Injury
Mayo Clinic 2,266
Testing effectiveness (Phase 2)Ended earlyNCT05370976
What this trial is testing

Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.

Who this might be right for
Cytomegalovirus Infections
University Hospital, Lille 2
Post-approval studies (Phase 4)Study completedNCT00138034
What this trial is testing

APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis -3

Who this might be right for
Myocardial Infarction
Heartcenter, University Medical Center St. Radboud 49
Testing effectiveness (Phase 2)Looking for participantsNCT06706258
What this trial is testing

Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)

Who this might be right for
Acute Kidney Injury
The University of Texas Health Science Center, Houston 400
Testing effectiveness (Phase 2)Study completedNCT03270748
What this trial is testing

Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies

Who this might be right for
Myeloid Malignancies
Gruppo Italiano Trapianto di Midollo Osseo 78
Next Page